M-2698
- Generic Name
- M-2698
- Drug Type
- Small Molecule
- Chemical Formula
- C21H19ClF3N5O
- CAS Number
- 1379545-95-5
- Unique Ingredient Identifier
- 0DXG50I4WD
- Background
M-2698 is under investigation in clinical trial NCT01971515 (First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies).
First-in-Human Dose Escalation Trial in Subjects With Advanced Malignancies
Phase 1
Completed
- Conditions
- Solid Tumor
- Interventions
- First Posted Date
- 2013-10-29
- Last Posted Date
- 2018-09-19
- Lead Sponsor
- EMD Serono
- Target Recruit Count
- 101
- Registration Number
- NCT01971515
- Locations
- 🇺🇸
University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸University of California at San Diego, Moores Cancer Center, San Diego, California, United States
🇺🇸Washington University School of Medicine, Saint Louis, Missouri, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath